Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sparrow BioAcoustics
Halifax, Nova Scotia, Canada
- Ownership
- Private
- Employees
- ~51
- Development stage
- Other
01
Overview
Sparrow BioAcoustics has commercialized the Stethophone, an FDA-cleared smartphone-based medical device that uses bioacoustic technology and artificial intelligence to detect cardiac and respiratory abnormalities. The company received FDA clearance in June 2023 for the software-as-a-medical-device application and Health Canada approval as a Class II medical device. The company launched Stethophone PRO in early 2025 for clinician use.
- Therapeutic areas
- CardiovascularPulmonology
- Modalities
- DeviceSoftware-as-a-medical-device
- Industry
- Physiological Monitoring
02
Partnerships
American Heart Association Center for Health Technology & Innovation
Beyond the preview
Go deeper on Sparrow BioAcoustics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sparrow BioAcoustics.